Skip to content

Whole-body vibration for childhood cancer patients after acute medical treatment – a pilot trial to assess feasibility and benefits

Whole-body vibration for childhood cancer patients after acute medical treatment – a pilot trial to assess feasibility and benefits - Whole-body vibration after pediatric cancer treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00010407
Enrollment
10
Registered
2016-04-26
Start date
2016-04-04
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

childhood cancer patients C00-D48

Interventions

Group 1: Intervention group includes childhood cancer patients (4-20 years) after inpatient medical treatment who participate in a vibration therapy program (Galileo® home) for 12 weeks. Vibration the

Sponsors

Deutsche Sporthochschule Köln, Insstitut für Kreislaufforschung und Sportmedizin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 20 Years

Inclusion criteria

Inclusion criteria: • Age: = 4 und = 20 years • pediatric cancer disease • completion off all inpatient medical treatment • cessation of inpatient medical treatment within the last 5 years • medical clearance (approval of the treating physician) • written informed consent from the legal guardian

Exclusion criteria

Exclusion criteria: • Exclusion criteria according to the manufacturer's recommendations • specific stress conditions (according to the physician’s advice) • specific physiological impairments that would make participation in functional motor testing or in the intervention not possible (according to the physician’s advice) • specific psychological impairments that would make participation in functional motor testing or in the intervention not possible (according to the physician’s advice)

Design outcomes

Primary

MeasureTime frame
As primary endpoint, the program’s feasibility is assessed. Therefore, training acceptance (questionnaire) and exercise-related adverse events are considered. The questionnaire will be completed after the end of the intervention. In addition, the number of completed training sessions, detailed training setup and reasons for non-participating/ drop out/ training interruption are documented.

Secondary

MeasureTime frame
First hints of possible benefits on functional performance of lower extremities, functional mobility, gait performance and physical activity behavior are analyzed. Secondary endpoints ae assessed before and after the intervention: - isometric strength of ankle dorsiflexion and knee extension (dynamometer) - active and passive ankle dorsiflexion range of motion (goinometer) - functional strength of lower extremity (standing long jump) - functional mobility (timed-up-and-go test) - time-walking-tests: [10m-walking test (free and fastest walking pace), 2min-walking test (walking efficiency)] -walk-to-run-transition time (treadmill test) - physical activiy behavior (activity questionnaire)

Countries

Germany

Contacts

Public ContactVanessa Oschwald

Deutsche Sporthochschule Köln, Institut für Kreislaufforschung und Sportmedizin

v.rustler@dshs-koeln.de0221-478-32993

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026